This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC, in collaboration with Solving Kids’ Cancer.

ACKNOWLEDGEMENT

This activity is supported by an educational grant from Y-mAbs Therapeutics, Inc.

DATE OF RELEASE/EXPIRATION

This activity was released on December 4, 2020 and is valid for 12 months. Requests for credit must be made no later than December 4, 2021.

TARGET AUDIENCE

The educational design of this activity addresses the needs of pediatric oncology nurses, advanced practice providers (including nurse practitioners and physician assistants), pediatric oncologists, social workers, and other members of the team caring for children with pediatric neuroblastoma.

STATEMENT OF NEED/PROGRAM OVERVIEW

Advanced practitioners have a vital role to play in the care of neuroblastoma, The most common extracranial solid tumor in childhood, with about 700 new cases in the US each year among children 14 and younger. Ad Immunotherapy promises to address a number of unmet therapeutic needs and improve the prognosis for patients with relapsed/refractory high-risk neuroblastoma.

Join a multidisciplinary panel of experts and patient advocates led by Dr. Shakeel Modak as they discuss emerging treatment options, including anti-GD2 agents, for high-risk relapsed/refractory pediatric neuroblastoma. Panelists will also review the determination of risk status, patient-selection criteria, and strategies to address adverse effects throughout the course of treatment. Learn strategies to educate and improve communication with patients, families, and caregivers from a patient advocate and parent on the panel to ensure greater care coordination.

PHYSICIAN ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PlatformQ Health Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION

Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING CONTINUING EDUCATION

Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 1.0 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

ESTIMATED TIME TO COMPLETE

This activity should take approximately 1 hour to complete.

INSTRUCTIONS TO RECEIVE CREDIT

In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FEE INFORMATION & REFUND/CANCELLATION POLICY

There is no fee for this educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter	Reported Financial Relationship
Shakeel Modak, MD Acting Chief, Neuroblastoma Service Attending, Pediatrics Memorial Sloan Kettering Cancer Center	Consultant/Independent Contractor: Illumina Radiopharmaceuticals, Y-mAbs Therapeutics, Inc. Grant/Research Support: Roche/Genentech Advisory Board: Progenics
Rachel Glincher, RN, MSN, CPNP-AC, CPHON Pediatric Nurse Practitioner Memorial Sloan Kettering Cancer Center	Other/Royalties: Rachel has no personal financial relationships. She works at Memorial Sloan Kettering Cancer Center (MSK) and MSK has institutional financial interests related to this research in the form of intellectual property rights and equity interests in Y-mAbs, the company licensing the intellectual property from MSK.
Donna Ludwinski Director of Research Advocacy Solving Kids’ Cancer	Nothing to disclose
Gregory Sizikov Caregiver Panelist	Nothing to disclose

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner or Manager	Reported Financial Relationship
Jaume Mascaro	Nothing to disclose
Emma Mayo	Nothing to disclose
Helen McCarthy-Tennant	Consultant/Independent Contractor: YmAbs Therapeutics, Inc.
Ashley Marostica, RN, MSN	Nothing to disclose
Lindsay Borvansky	Nothing to disclose
Andrea Funk	Nothing to disclose
Liddy Knight	Nothing to disclose
Ashley Cann	Nothing to disclose
Jaimee Harris-Gold	Nothing to disclose
Tariqa Ackbarali	Nothing to disclose

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PlatformQ Health Education, LLC. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support: For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Technical Support: For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com.